SHP Wealth Management’s Cidara Therapeutics CDTX Stock Holding History

SHP Wealth Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$1.1K	–	1834
2025 Q4	$1.1K	Buy	+5	New	+$808	﹤0.01%	1240

SHP Wealth Management's CDTX Position: Q1 2026 in Review

SHP Wealth Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 5 shares — an estimated $1.1K sold.

SHP Wealth Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.1K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

SHP Wealth Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
SHP Wealth Management sold 5 Cidara Therapeutics shares in Q1 2026, an estimated $1.1K.
SHP Wealth Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
SHP Wealth Management's Cidara Therapeutics position peaked at $1.1K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.